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Abstract
Rotavirus is the most important cause of severe childhood gastroenteritis worldwide. Rotavirus 
vaccines are available and rotavirus surveillance is carried out to assess vaccination impact. In 
surveillance studies, stool samples are stored typically at 4°C or frozen to maintain sample quality. 
Uninterrupted cold storage is a problem in developing countries because of power interruptions. 
Cold-chain transportation of samples from collection sites to testing laboratories is costly. In this 
study, we evaluated the use of BBL™ Sensi-Discs™ and FTA® cards for storage and 
transportation of samples for virus isolation, EIA, and RT-PCR testing. Infectious rotavirus was 
recovered after 30 days of storage on Sensi-Discs™ at room temperature. We were able to 
genotype 98–99% of samples stored on Sensi-Discs™ and FTA® cards at temperatures ranging 
from −80°C to 37°C up to 180 days. A field sampling test using samples prepared and shipped 
from Cameroon, showed that both matrices yielded 100% genotyping success compared with 
whole stool and Sensi-Discs™ demonstrated 95% concordance with whole stool in EIA testing. 
The utilization of BBL™ Sensi-Discs™ and FTA® cards for stool sample storage and shipment 
has the potential to have great impact on global public health by facilitating surveillance and 
epidemiological investigations of rotavirus strains worldwide at a reduced cost.
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Group A rotavirus is the most common cause of pediatric gastroenteritis and is estimated to 
kill over 453,000 children annually, mostly in low-income countries (Tate et al., 2012). Two 
live-attenuated oral vaccines, RotaTeq® (Chandran and Santosham, 2008) and Rotarix® 
(Ward and Bernstein, 2009), have shown efficacy against severe rotavirus disease in large 
clinical trials. The World Health Organization (WHO) has recommended routine 
immunization against rotavirus in all countries. Between 2006 and 2015, 75 countries 
introduced rotavirus vaccines into national immunization programs, and subsequently, the 
burden of severe rotavirus disease decreased substantially in those countries (http://
sites.path.org/rotavirusvaccine/rotavirus-advocacy-and-communications-toolkit/country-
introduction-maps-and-list/; Patel et al., 2012; Steele, 1998).
Rotavirus surveillance is carried out to monitor circulating rotavirus genotypes, detect 
possible emerging or novel rotavirus strains, and assess the impact of vaccination (Gentsch 
et al., 2009; Hull et al., 2011; Santos and Hoshino, 2005). In surveillance studies, stool 
samples from gastroenteritis cases are transported to reference laboratories for confirmatory 
testing and genetic characterization and are typically stored at 4°C or frozen to maintain 
sample quality. Uninterrupted cold storage is a problem in many laboratories due to power 
interruptions, particularly in developing countries. Cold-chain transportation of samples 
from collection sites to testing laboratories requires dry ice or cold-packs thus making 
international shipping very expensive and, in some locations, dry ice cannot be obtained 
easily.
Routine diagnosis of rotavirus is often based on rapid detection of group A rotavirus antigen 
in stool, generally by enzyme immunoassay or latex agglutination assay (van Doorn et al., 
2009). Since these serological assays do not distinguish accurately between different 
rotavirus serotypes (Gouvea et al., 1990), genotyping is typically performed for analysis of 
the rotavirus genomic RNA. Reverse transcription PCR (RT-PCR) is used to detect rotavirus 
RNA and identify VP7 (G) and VP4 (P) genotypes (Matthijnssens et al., 2008). In addition 
to conventional RT-PCR, quantitative real-time RT-PCR (qRT-PCR) assays offer several 
advantages for detection such as increased sensitivity, higher-throughput and faster turn-
around time, as well as the ability to perform quantification of viral loads (Mijatovic-
Rustempasic et al., 2013).
In many rotavirus surveillance studies and/or vaccine trials, stool samples need to be 
transported to reference laboratories for genetic characterization. Currently, this involves 
shipping stool-filled containers or soiled diapers under cooled and biohazardous conditions. 
In field situations in some developing countries, where electricity and/or skilled laboratory 
technicians are not available, the simple task of sample collection, aliquoting, and freezing 
can present as a challenge. To remedy these issues, Rahman and coworkers described the 
use of SDS-EDTA pretreated chromatography filter paper strips for collection, transport, 
and storage of rotavirus samples (Rahman et al., 2004). Although rotavirus RNA was stable 
for up to 30 days at room temperature and higher temperatures, no live virus or rotavirus 
antigen were detected in the culture supernatant inoculated with the pretreated strip. 
Shulman and coworkers reported the use of rapid test strips (dipsticks) for collection of 
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rotavirus samples (Shulman et al., 2011) and was able to G and P genotype 40–92% of 
rotavirus samples that had been stored on dried dipsticks at room temperature for up to 5 
years. Several bioscience companies also offer commercially available RNA stabilization 
and storage reagents (e.g., RNAlater® Life Technologies, Grand Island, NY USA) that 
protect cellular RNA and inactivate RNase activity to allow later processing. However, these 
collection and storage methods are purposely designed for RNA isolation and molecular 
testing (genotyping and/or sequencing), do not permit antigen detection and/or virus 
isolation from stool samples, and are costly. For example, RNAlater® costs US$1.87 per 
sample if purchased in bulk (2015 list price from Life Technologies.)
BBL™ Sensi-Disc™ antimicrobial susceptibility test discs (Sensi-Disc™, Fisher Scientific, 
MA USA) were intended to be used for semi-quantitative in vitro antibiotic susceptibility 
testing of common, rapidly growing and certain fastidious bacterial pathogens by the agar 
disc diffusion test procedure (BDDiagnostic, 2011). Sensi-Discs™ are available 
impregnated with 30mg of Cefepime, a semi-synthetic fourth-generation cephalosporin with 
broad spectrum of activity against gram-positive and gram-negative bacteria (Yahav et al., 
2007) that are commonly found in stool samples. We hypothesize that the presence of 
Cefepime would inhibit the growth of stool bacteria on these discs thus preserving rotavirus 
particles, proteins, and RNA for subsequent testing.
The Whatman FTA® card (GE Healthcare, UK) is a commercial product for the collection, 
storage, preservation, and processing of nucleic acids. The paper contains proprietary 
chemicals which lyse cellular material and fix and preserve DNA and RNA within a fiber 
matrix (http://www.whatman.com.cn/upload/starjj_200941413246.pdf). Once immobilized 
on the cards, the samples are no longer infectious and thus do not pose a biohazard (Picard-
Meyer, Barrat, and Cliquet, 2007). DNA bound to FTA® cards can be stored at room 
temperature for years with high stability (http://www.whatman.com.cn/upload/
starjj_2009414132332.pdf). The FTA® cards have been used effectively for a variety of 
infectious agents, such as human papillomavirus, malaria, avian influenza, rabies, and 
Mycobacterium leprae (Aye et al., 2011; Gonzalez et al., 2012; Keeler et al., 2012; Picard-
Meyer et al., 2007; Zhong et al., 2001) but have not previously been evaluated for the 
detection of rotaviruses.
The purpose of this study is to evaluate two novel methods for collection, storage and 
shipping of stool specimens for rotavirus testing that will potentially allow us to perform 
EIA, genotyping, as well as isolation of live virus (Sensi-Disc™). These two novel methods 
will potentially allow researchers to store and ship specimens at ambient temperature which 
will greatly reduce shipping costs and avoid problems with storage and/or shipping when the 
cold chain is interrupted. In this study, different incubation temperatures of a cultured 
rotavirus strain and rotavirus positive stool samples were investigated for their effect on the 
stability of rotaviruses for subsequent detection using EIA, qRT-PCR and conventional RT-
PCR for both the Sensi-Disc™ and the FTA® card. We believe that the wide range of 
temperatures tested simulate different conditions that the samples might encounter during 
storage and shipment internationally.
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2. Materials and Methods
2.1 Propagation of virus
Reference rotavirus strain Wa (G1P[8], ATCC VR-2018) was propagated in the monkey 
kidney cell line MA-104 (ATCC CRL-2378). Briefly, MA-104 cells were grown in 
monolayer cultures using Iscove's Modified Dulbecco's Media (IMDM) (GIBCO© 
Laboratories, Grand Island, NY USA). A standard plaque assay was used to determine the 
titer of Wa stocks (Albert and Bishop, 1984; Wyatt et al., 1983). Aliquots of Wa lysate 
product at 107 PFU/mL were stored at −80°C until further use.
2.2 Sample preparation
Cell culture lysates (40μL) or rotavirus positive stool samples were spotted onto the center 
of 6 mm diameter Sensi-Disc™ discs (BD, Cat. No 231695) and 10 mm diameter pre-
punched FTA® cards (Whatman, Cat. No WB120305). The FTA cards were pre-punched 
from card stock in the lab with a sterilized 10 mm hole punch and stored in zipper seal bags 
until used. The samples then were allowed to dry at room temperature (22±2°C) inside a 
biosafety cabinet overnight. The samples (1–3 per experiment) were then stored in 2 x 3 
inch polyethylene zipper seal sample bags (Fisher Healthcare, PA USA) with a SORBIT 
0.5G desiccant canister (AGM Container Controls, AZ USA) inside cardboard boxes at 5 
different temperatures (37°C, 22±2°C, 4°C, −20°C, and −80°C) for 1–180 days. The wide 
range of temperatures was chosen to mimic temperatures that one might encounter when 
samples are stored and then shipped internationally on dry ice, cold packs, or ambient 
temperature.
2.3 Viability of rotavirus on FTA cards and Sensi-Discs
To study the viability of rotavirus on Sensi-Discs™ and FTA® cards, replicates of 40μL of 
Wa lysate product were dried on Sensi-Discs™ and FTA® cards. Virus isolation was 
attempted from Sensi-Discs™ and FTA® cards after 24 hours of incubation at room 
temperature and after 30 days (Sensi-Discs™ only). Each Sensi-Disc™ and FTA® card was 
placed into a 1.5mL Eppendorf tube containing 400μL of IMDM, vortexed and incubated at 
room temperature for 4 hours. Trypsin-activated supernatants were used to infect MA-104 
cells as described previously (Albert and Bishop, 1984). A second and third blind passage 
was carried out in case of negative results on initial virus isolation attempts. The elution and 
all passages were tested for the presence of rotavirus antigen by performing an enzyme-
linked immunosorbent assay (EIA) using the Premier™ Rotaclone® kit (Meridian 
BioScience, Cincinnati, OH USA). RNA was extracted from the supernatant using the 
MagMax 96 Viral RNA Isolation kit (Applied Biosystems, Inc., Foster City, CA USA) on 
the KingFisher Flex Magnetic Particle Processor (Thermo Fisher Scientific, Pittsburgh, PA 
USA) according to the manufacturer’s instructions. NSP3 gene qRT-PCR was conducted 
using an ABI 7500 Fast real time PCR instrument (Applied Biosystems, Inc., Foster City, 
CA USA) and rTth enzyme (Life Technologies, Grand Island, NY USA) as described 
previously (Mijatovic-Rustempasic et al., 2013). Positive-control RNA template was 
generated from the Rotavirus A NSP3 gene of laboratory strain Wa RNA as described 
previously (Mijatovic-Rustempasic et al., 2013); 10-fold dilutions of the transcript from 
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10−4 to 10−10 were prepared tested by qRT-PCR to generate a standard curve for calculation 
of copy numbers (Mijatovic-Rustempasic et al., 2013).
2.4 Stability of rotavirus nucleic acid on Sensi-Discs™ and FTA® cards
To study the stability of rotavirus nucleic acid on Sensi-Disc™ and FTA® cards, replicates 
(3 per data point) of 40 μL of Wa lysate product were spotted onto Sensi-Discs™ and FTA® 
cards, dried, and then stored as described above for 28 days. Each Sensi-Disc™ and FTA® 
card then was eluted in 400μ.L of TE buffer (10mM Tris-HCl, 0.1mM EDTA, pH 8.0) at 
room temperature for 4 hours in a 1.5mL Eppendorf tube. RNA extraction was performed on 
the elutions using a MagMAX™ Viral RNA isolation kit (Applied Biosystems, Inc., Foster 
City, CA USA) according to the manufacturer’s instructions and then tested with the NSP3 
gene qRT-PCR as described previously (Mijatovic-Rustempasic et al., 2013).
2.5 VP7 and VP4 genotyping of rotavirus
To evaluate the molecular detection and VP7 and VP4 genotyping of samples inoculated 
onto Sensi-Discs™ and FTA® cards, replicates of three rotavirus positive stool samples 
were spotted onto Sensi-Discs™ and FTA® cards, dried, and stored as described above. The 
rotavirus positive samples selected were liquid, semi-solid, and solid, representing the 
different consistencies of stool that one would encounter when testing. Each Sensi-Disc™ 
and FTA® card was eluted in 400μ.L of TE buffer and extractions were performed on 
elutions as described above. Elutions were tested for rotavirus antigen by performing EIA 
using the Premier™ Rotaclone® kit. RNA extraction was performed as described and RT-
PCR genotyping and sequencing of rotavirus VP7 and VP4 genes were carried out as 
described previously (Hull et al., 2011) on randomly selected samples to ensure there was no 
cross contamination from other rotavirus strains during the study.
2.6 Field sampling test
For a field sampling evaluation, 50 stool samples (40 rotavirus positive and 10 rotavirus 
negative) collected at the rotavirus sentinel surveillance site at the Mother and Child Center, 
Chantal Biya Foundation Yaoundé, Cameroon and previously screened for rotavirus antigen 
as well as genotyped for VP7 and VP4, were dried onto Sensi-Discs™ and FTA® cards as 
described and shipped 10 days later at ambient temperature to the Centers for Disease 
Control and Prevention, Atlanta GA USA. Aliquots of each whole stool sample were 
shipped also on dry ice/ice packs. After preparing 10% suspensions of whole stool in PBS, 
EIA, sample elution, RNA extraction, and RT-PCR genotyping for VP7 and VP4 genes 
were carried out on all samples as described previously.
2.7 Statistics
Statistical analysis was performed by using EXCEL 2010.
3. Results
3.1 Viability of rotavirus on Sensi-Discs™ and FTA® cards
Virus isolation was attempted from elutions of Wa spotted Sensi-Discs™ and FTA® cards. 
For Sensi-Discs™, both viral antigens and viral RNA were detected in the eluted material, 
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as well as in successive passages inoculated with the elution of Sensi-Discs™ after 1 day of 
incubation. The same result was observed from elution of Sensi-Discs™ after 30 days of 
incubation, showing that the virus remained intact and infectious after being dried on Sensi-
Discs™ with prolonged storage at room temperature (Table 1). For FTA® cards, both viral 
antigens and viral RNA were detected in the eluted material on day 1 but not in cell culture 
passages inoculated with the FTA® card eluate, indicating that live virus was not recovered 
from the matrix. Since live virus could not be recovered from the FTA® cards on day 1, 
virus isolation was not attempted on day 30. There was no apparent change in appearance of 
both Sensi-Discs™ and FTA® cards after 30 days of incubation.
3.2 Stability of rotavirus nucleic acid
To test the stability of rotavirus nucleic acid dried on Sensi-Discs™ and FTA® cards, RNA 
extraction was performed on eluted material and tested by NSP3 gene qRT-PCR for 
quantification of recovered RNA. Viral RNA was preserved with little loss over 28 days of 
storage at various incubation temperatures for both the Sensi-Discs™ and FTA® cards 
(Figure 1). The mean copy number per μ.L of stool ranged within a 3 fold difference in RNA 
concentration recovered after 28 days of storage at 37°C, for both the Sensi-Discs™ and 
FTA® cards. It should be noted that there was an approximate 10-fold decrease in RNA 
recovered after the sample was dried on the Sensi-Discs™ overnight, but was not observed 
for RNA dried on FTA® cards.
3.3 VP7 and VP4 genotyping of rotavirus
For molecular characterization of rotavirus eluted from FTA cards and Sensi-Discs™, we 
attempted genotyping for the VP7 and VP4 genes. Sequence confirmation of both genes was 
performed on randomly selected samples to ensure there was no cross contamination from 
other rotavirus strains during the study. Three rotavirus positive stool samples were tested 
with 3 replicates at each time point for each storage temperature. We were able to genotype 
312/315 (99%) and 253/260 (98%) of the samples that were recovered from Sensi-Disc™ 
and FTA® cards, respectively (Table 2). Weaker PCR product bands were seen by gel 
electrophoresis for nucleic acid stored on Sensi-Discs™ and FTA® cards that were stored at 
37°C (data not shown), and 3 out of the 9 samples were not genotyped when nucleic acid 
was stored on FTA® cards for 180 days at 37°C (Table 2).
3.4 Field sampling test
For the field sampling test, we were able to genotype all 40 rotavirus positive samples 
regardless of which condition the samples were shipped (Table 3). However, 2 (5%) and 7 
(17.5%) out of 40 samples that were dried on Sensi-Discs™ and FTA® cards, respectively, 
were negative by EIA upon retest; all 40 whole stools were positive when retested (Table 3). 
The 10 rotavirus negative samples, included to ensure that there were no false positives or 
that cross contamination didn’t occur during sampling, all tested negative for EIA and 
genotyping in all three storage formats (Table 3). Virus isolation was not attempted because 
of the inefficiency and complexity of isolating rotavirus from stool. The total cost for the 
Sensi-Disc™ and FTA® cards shipment (US$138.47) at ambient temperature from 
Yaounde, Cameroon to Atlanta, USA was 5.4 fold less than the cost (US$ 747.79) of the dry 
ice shipment.
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In rotavirus surveillance studies, stool samples from gastroenteritis cases typically are 
transported from sentinel sites to reference laboratories for EIA testing and genetic 
characterization. In this study, we dried stool samples onto Sensi-Discs™ and FTA® cards 
in an attempt to replace high-cost cold-chain storage and transportation, which is often 
difficult to maintain developing countries. We decided to store dried samples over a large 
range of temperatures over an extended period of time in order to mimic temperature(s) that 
samples might encounter during shipment internationally. Also, we decided to elute at room 
temperature for a longer period of time, versus at higher temperature for a shorter period of 
time like most standard protocols recommended by manufacturers, in consideration of some 
laboratories in developing countries which may not have the luxury of a heating apparatus. 
The two matrices evaluated in this study will allow researchers to store and ship specimens 
at ambient temperature with greatly reduced shipping costs and avoid problems with storage 
and/or shipping where the cold chain might be interrupted. Although other sampling devices 
(Rahman et al., 2004; Shulman et al., 2011) and commercially available RNA stabilization 
storage reagents such as RNAlater® are available, we have shown that RNA can be stably 
stored on FTA® card and Sensi-Disc™ at temperatures as high as 37°C for up to 180 days. 
FTA® cards allow transportation of samples without special handling (i.e., biohazardous 
material shipping). Sensi-Discs™ allows antigen detection and potentially virus isolation 
from stool samples which could be important in some studies.
This study revealed stability of rotavirus RNA on FTA® cards and Sensi-Discs™ stored at 
different temperatures over prolonged incubation periods. RNA extracted from elutions of 
FTA® cards were detectable by qRT-PCR, as well as by conventional genotyping and 
sequencing. For FTA® cards, complete inactivation of cultured strain Wa was demonstrated 
along with negative results for rotavirus antigen detection. . This demonstrated that samples 
spotted on FTA® cards are non-infectious and can be sent internationally without biohazard 
shipping at ambient temperature. Although Sensi-Disc™ requires biohazard shipment 
packaging, it serves as a possible alternative when virus re-isolation is desired as we were 
able to propagate cultured strain Wa from Sensi-Disc™ elutions even after 30 days of 
storage.
The loss of sensitivity of RNA detection compared to conventional methods of sample 
transport and loss of some EIA positive samples after a field sampling test are limitations. 
However, initial EIA testing was routinely done on site, and (EIA) positive samples were 
usually sent for further molecular analysis. For EIA positive samples, virus concentration 
has been estimated to be minimum of 106 virus particles/mL, therefore a 10 fold loss should 
not affect the quality and accuracy of molecular results which can detect rotavirus RNA at 
much lower concentrations.
To the best of our knowledge, this is the first study using FTA® cards for rotavirus sampling 
and is the first use of Sensi-Discs™ as a sampling device. The use of Sensi-Disc™ and 
FTA® cards will be of potential great value for transport of samples at a greatly reduced 
shipping cost without the necessity of a cold chain. Sometimes delivery delays of dry ice 
shipments due to customs clearance delays or other issues can result in thawing of rotavirus 
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positive stool samples and degradation of sample quality. The temperature stability of 
samples collected on these discs also will allow laboratories to store specimens without 
using refrigerators or freezers. In developing countries laboratories, where uninterrupted 
cold storage is often a problem due to electrical interruptions, the use of these discs can 
greatly improve sample quality since the stool samples would not be subjected to repeated 
temperature changes. In addition, the reduced costs of shipping samples to reference 
laboratories for analysis will enhance the ability to maintain long term surveillance in 
vaccination monitoring programs, as we demonstrated a greater than 80% reduction in 
shipping costs in our field test. The cost per sample is also very low for the FTA card 
punched discs and Sensi-Discs™, US$0.29 and US$0.26 per disc, respectively. This 
approach will support and strengthen rotavirus surveillance and epidemiology programs as 
well as improve our laboratory services. The use of FTA® cards would be advantageous for 
the transportation of material from site to site and during outbreak investigations, would be 
fast and safe, while the use of Sensi-Discs™ can replace the routine collection of stool 
samples in vials or larger containers that would eventually be tested by virus isolation, EIA, 
and genotyping. We believe that it would be highly advantageous to use FTA® cards as 
sampling device in genotyping studies and Sensi-Disc™ in studies that require EIA testing, 
genotyping, and possibly virus isolation.
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Results of qRT-PCR targeting the NSP3 gene (copy number/μ.L stool) using RNA extracted 
from (a) Sensi-Discs™ (b) FTA® cards spotted with Wa lysate product and incubated at 
various temperatures for a duration of 28 days. Each data point represents 3 replicates; error 
bars are equal to one standard deviation.
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